Literature DB >> 7509833

Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy.

L Mincheva-Nilsson1, V Baranov, M M Yeung, S Hammarström, M L Hammarström.   

Abstract

Human decidual lymphocytes from early, normal pregnancy were characterized in situ with respect to ultrastructure and distribution of subsets. The ultrastructure of isolated decidual gamma delta T cells was also studied. CD45+ cells comprised 11 +/- 2% of all decidual cells. The majority were localized in large lymphoid cell clusters (LCC), near endometrial glands, or as intraepithelial lymphocytes (IEL) in glandular epithelium. The major cell populations in LCC were CD56+TCR-gamma delta+ cells, CD56+ cells, TCR-alpha beta+CD4+ cells, and TCR-alpha beta+CD8+ cells. All expressed activation markers (CD45RO, Kp43, and/or HML-1) and MHC class II Ag (HLA-DR, HLA-DP, and/or HLA-DQ). No B cells were found. Almost all IEL were activated TCR-gamma delta+ cells (CD56+ and CD56-). The glandular epithelial cells expressed heat shock protein 60 at the basolateral side facing the TCR-gamma delta+ IEL. Decidual lymphocytes displayed cytoplasmic processes, microvilli, characteristic cytoplasmic granules, and had intimate contact with neighboring cells. Lymphocytes in the outer rim of LCC and the stroma showed signs of cellular movement. Two main morphotypes of gamma delta T cells could be distinguished. One had single microvilli, membrane-bound granules, and nuclear inclusions. The other had many microvilli, nonmembrane-bound granules and cytoplasmic multivesicular bodies. Our data suggest that LCC are centers of immune reactivity where T and NK cells become activated. The activated cells may guard against infections and undue trophoblast invasion and/or be involved in modulating the local maternal immune system toward unresponsiveness against the semiallogeneic fetus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509833

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus.

Authors:  Y Dang; J Beckers; C R Wang; K D Heyborne
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

Review 2.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  The Role of Progesterone in Feto-Maternal Immunological Cross Talk.

Authors:  Julia Szekeres-Bartho
Journal:  Med Princ Pract       Date:  2018-06-27       Impact factor: 1.927

Review 4.  Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract.

Authors:  Iara Moreno Linhares; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2010-02-25       Impact factor: 3.667

5.  Human decidua contains potent immunostimulatory CD83(+) dendritic cells.

Authors:  U Kämmerer; M Schoppet; A D McLellan; M Kapp; H I Huppertz; E Kämpgen; J Dietl
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua.

Authors:  Y-L Ban; B-H Kong; X Qu; Q-F Yang; Y-Y Ma
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

7.  Expression and function of PDCD1 at the human maternal-fetal interface.

Authors:  Elizabeth S Taglauer; Ann S Trikhacheva; Joyce G Slusser; Margaret G Petroff
Journal:  Biol Reprod       Date:  2008-06-11       Impact factor: 4.285

Review 8.  Immunity to heat shock proteins and pregnancy outcome.

Authors:  S S Witkin
Journal:  Infect Dis Obstet Gynecol       Date:  1999

9.  Role of uterine natural killer cells and interferon gamma in placental development.

Authors:  R W Redline
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

Review 10.  Pregnancy and gamma/delta T cells: taking on the hard questions.

Authors:  Lucia Mincheva-Nilsson
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.